Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 9/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 7/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19628161 | 0.94 | GSTP1 (0.36) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL19628162 | 0.93 | S1PR5 (0.36) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL19628166 | 0.91 | S1PR5 (0.39) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL19628158 | 0.91 | LIMK1 (0.38) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL19628167 | 0.91 | GPR84 (0.35) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL19628164 | 0.90 | CA12 (0.37) | S1PR5S1PR4GSTP1LIMK1ALOX5 | |
| SCHEMBL19628153 | 0.89 | ALOX5 (0.41) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL19628174 | 0.85 | GPR84 (0.32) | S1PR5S1PR4GSTP1GPR84LIMK1 | |
| SCHEMBL19628165 | 0.85 | GPR84 (0.34) | S1PR5S1PR4GSTP1GPR84LIMK1 | |
| SCHEMBL19628179 | 0.84 | ALOX5 (0.38) | CYP1A2ERBB2FYNMAOAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10439144-B2 | Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device | UNIVERSITY-INDUSTRY COOPERATEON GROUP OF KYUNG HEE UNIVERSITY (KR) | 2019-10-08 | — | — | US | disclosed |
| US-20170338416-A1 | ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2017-11-23 | — | — | US | disclosed |
| US-20170338416-A1 | ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10439144-B2 | Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device | OR10J3, OCIAD2, OCIAD1 | CYP1A2 509/4885ERBB2 613/4885FYN 1530/4885 |
| US-20170338416-A1 | ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE | OR10J3, OCIAD2, OCIAD1 | CYP1A2 509/4885ERBB2 613/4885FYN 1530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.